Article
Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate.
Bioorganic & medicinal chemistry letters - 15 Feb 2017
Keung Walter, Boloor Amogh, Brown Jason, Kiryanov Andre, Gangloff Anthony, Lawson J David, Skene Robert, Hoffman Isaac, Atienza Josephine, Kahana Jason, De Jong Ron, Farrell Pamela, Balakrishna Deepika, Halkowycz Petro
Abstract excerpt
Axl has been a target of interest in the oncology field for several years based on its role in various oncogenic processes. To date, no wild-type Axl crystal structure has been reported. Herein, we describe the structure-based optimization of a novel chemotype of Axl inhibitors, 1H-imidazole-2-carboxamide, using a mutated kinase homolog, Mer(I650M), as a crystallographic surrogate. Iterative optimization of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
